Evren Sevan, Khoury Thaer, Neppalli Vishalla, Cappuccino Helen, Hernandez-Ilizaliturri Francisco J, Kumar Prasanna
Department of Medical Oncology, Roswell Park Cancer Institute, Buffalo, NY, USA.
Department of Pathology, Roswell Park Cancer Institute, Buffalo, NY, USA.
Am J Case Rep. 2017 May 31;18:605-610. doi: 10.12659/ajcr.903161.
BACKGROUND Anaplastic large cell lymphomas (ALCL) are a rare type of primary breast lymphoma. The association between breast implants and ALCL was first described in 1997 and since then 34-173 cases have been presented. The annual incidence of breast implant-associated ALCL (BI-ALCL) is 0.1-0.3 per 100 000 women who undergo breast reconstruction, and cases are often underreported due to the rarity of these tumors. BI-ALCL arises from the inflammatory T cells surrounding the fibrous capsule, and most tumors are in situ. CASE REPORT Here, we present the case of a 51-year-old woman with ALCL following bilateral silicone breast implants. The patient presented with breast enlargement and tenderness 9 years following reconstructive surgery. Imagining studies showed fluid collection surrounding the affected breast implant. Staging studies and histocytopathology examination confirmed the presence BI-ALCL without capsular invasion or metastasis. Complete surgical excision was performed. The patient continues to be in complete remission. CONCLUSIONS Due to the rarity of these tumors, establishing the diagnosis of BI-ALCL can be challenging and requires a multidisciplinary approach. Clinicians should be aware of the relationship between breast implants and BI-ALCL.
间变性大细胞淋巴瘤(ALCL)是原发性乳腺淋巴瘤的一种罕见类型。乳房植入物与ALCL之间的关联于1997年首次被描述,自那时起已报告了34至173例病例。每10万名接受乳房重建的女性中,乳房植入物相关ALCL(BI-ALCL)的年发病率为0.1至0.3,由于这些肿瘤罕见,病例往往报告不足。BI-ALCL起源于纤维囊周围的炎性T细胞,大多数肿瘤为原位肿瘤。病例报告:在此,我们报告一例51岁双侧硅胶乳房植入术后发生ALCL的女性病例。患者在重建手术后9年出现乳房增大和压痛。影像学检查显示受影响乳房植入物周围有积液。分期检查和组织细胞病理学检查证实存在BI-ALCL,无包膜侵犯或转移。进行了完整的手术切除。患者持续完全缓解。结论:由于这些肿瘤罕见,确立BI-ALCL的诊断具有挑战性,需要多学科方法。临床医生应了解乳房植入物与BI-ALCL之间的关系。